Patents by Inventor Ebbe Briggs BØDTKJER

Ebbe Briggs BØDTKJER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190085074
    Abstract: Antibodies or antigen binding fragment thereof specifically recognizing and binding an extracellular polypeptide region of human NBCn1 are provided. Moreover, the medical use of such antibodies is provided, in particular such use for the treatment of hyperproliferative disorders, such as cancer, or atherosclerosis and/or restenosis. Methods for producing such antibodies are also provided.
    Type: Application
    Filed: November 30, 2018
    Publication date: March 21, 2019
    Inventor: Ebbe Briggs BØDTKJER
  • Publication number: 20180057588
    Abstract: The present application discloses antibodies or antigen binding fragment thereof specifically recognizing and binding an extracellular polypeptide region of human NBCn1. Experimental data are detailed for mouse NBCn1 antibodies. The medical use of such antibodies is claimed, in particular for the treatment of hyperproliferative disorders, such as cancer, or atherosclerosis and/or restenosis.
    Type: Application
    Filed: March 16, 2016
    Publication date: March 1, 2018
    Inventor: Ebbe Briggs BØDTKJER